Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer

Emily M. Hinchcliff, Anne Knisely, Naomi Adjei, Bryan Fellman, Ying Yuan, Ami Patel, Cai Xu, Shannon N. Westin, Anil K. Sood, Pamela T. Soliman, Aaron Shafer, Nicole D. Fleming, David M. Gershenson, Raghunandan Vikram, Tharakeswara Bathala, David Vining, Dhakshina M. Ganeshan, Karen H. Lu, Charlotte C. Sun, Larissa A. MeyerAmir A. Jazaeri

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences